191 related articles for article (PubMed ID: 31152749)
1. Local inflammation alters the lung disposition of a drug loaded pegylated liposome after pulmonary dosing to rats.
Haque S; Feeney O; Meeusen E; Boyd BJ; McIntosh MP; Pouton CW; Whittaker M; Kaminskas LM
J Control Release; 2019 Aug; 307():32-43. PubMed ID: 31152749
[TBL] [Abstract][Full Text] [Related]
2. Swellable ciprofloxacin-loaded nano-in-micro hydrogel particles for local lung drug delivery.
Du J; El-Sherbiny IM; Smyth HD
AAPS PharmSciTech; 2014 Dec; 15(6):1535-44. PubMed ID: 25079240
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the lung clearance kinetics of solid lipid nanoparticles and liposomes by following the
Haque S; Whittaker M; McIntosh MP; Pouton CW; Phipps S; Kaminskas LM
Eur J Pharm Biopharm; 2018 Apr; 125():1-12. PubMed ID: 29309835
[TBL] [Abstract][Full Text] [Related]
4. In-vitro and in-vivo evaluation of ciprofloxacin liposomes for pulmonary administration.
Liu C; Shi J; Dai Q; Yin X; Zhang X; Zheng A
Drug Dev Ind Pharm; 2015 Feb; 41(2):272-8. PubMed ID: 24252110
[TBL] [Abstract][Full Text] [Related]
5. Prolonged distribution of aerosolized PEGylated liposomes in the lungs of mice with bleomycin-induced pulmonary fibrosis.
Togami K; Maruta Y; Nanbu M; Tada H; Chono S
Drug Dev Ind Pharm; 2020 Nov; 46(11):1873-1880. PubMed ID: 32940095
[TBL] [Abstract][Full Text] [Related]
6. Model Calculations of Regional Deposition and Disposition for Single Doses of Inhaled Liposomal and Dry Powder Ciprofloxacin.
Martin AR; Finlay WH
J Aerosol Med Pulm Drug Deliv; 2018 Feb; 31(1):49-60. PubMed ID: 28708440
[TBL] [Abstract][Full Text] [Related]
7. Lung injury from intratracheal and inhalation exposures to residual oil fly ash in a rat model of monocrotaline-induced pulmonary hypertension.
Kodavanti UP; Jackson MC; Ledbetter AD; Richards JR; Gardner SY; Watkinson WP; Campen MJ; Costa DL
J Toxicol Environ Health A; 1999 Aug; 57(8):543-63. PubMed ID: 10515573
[TBL] [Abstract][Full Text] [Related]
8. Penetration of Ciprofloxacin and Amikacin into the Alveolar Epithelial Lining Fluid of Rats with Pulmonary Fibrosis.
Ni W; Yang D; Mei H; Zhao J; Liang B; Bai N; Chai D; Cui J; Wang R; Liu Y
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115351
[TBL] [Abstract][Full Text] [Related]
9. Inhalable Levofloxacin Liposomes Complemented with Lysozyme for Treatment of Pulmonary Infection in Rats: Effective Antimicrobial and Antibiofilm Strategy.
Gupta PV; Nirwane AM; Nagarsenker MS
AAPS PharmSciTech; 2018 Apr; 19(3):1454-1467. PubMed ID: 29464594
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin Conjugation and Drug Linker Chemistry Alter the Intravenous and Pulmonary Pharmacokinetics of a PEGylated Generation 4 Polylysine Dendrimer in Rats.
Leong NJ; Mehta D; McLeod VM; Kelly BD; Pathak R; Owen DJ; Porter CJH; Kaminskas LM
J Pharm Sci; 2018 Sep; 107(9):2509-2513. PubMed ID: 29852134
[TBL] [Abstract][Full Text] [Related]
11. Macrophage-targeted drugamers with enzyme-cleavable linkers deliver high intracellular drug dosing and sustained drug pharmacokinetics against alveolar pulmonary infections.
Su FY; Srinivasan S; Lee B; Chen J; Convertine AJ; West TE; Ratner DM; Skerrett SJ; Stayton PS
J Control Release; 2018 Oct; 287():1-11. PubMed ID: 30099019
[TBL] [Abstract][Full Text] [Related]
12. Fate of PEGylated antibody fragments following delivery to the lungs: Influence of delivery site, PEG size and lung inflammation.
Patil HP; Freches D; Karmani L; Duncan GA; Ucakar B; Suk JS; Hanes J; Gallez B; Vanbever R
J Control Release; 2018 Feb; 272():62-71. PubMed ID: 29247664
[TBL] [Abstract][Full Text] [Related]
13. Treatment of pulmonary fibrosis with siRNA against a collagen-specific chaperone HSP47 in vitamin A-coupled liposomes.
Otsuka M; Shiratori M; Chiba H; Kuronuma K; Sato Y; Niitsu Y; Takahashi H
Exp Lung Res; 2017; 43(6-7):271-282. PubMed ID: 29035148
[TBL] [Abstract][Full Text] [Related]
14. Lung targeted liposomes for treating ARDS.
Arber Raviv S; Alyan M; Egorov E; Zano A; Harush MY; Pieters C; Korach-Rechtman H; Saadya A; Kaneti G; Nudelman I; Farkash S; Flikshtain OD; Mekies LN; Koren L; Gal Y; Dor E; Shainsky J; Shklover J; Adir Y; Schroeder A
J Control Release; 2022 Jun; 346():421-433. PubMed ID: 35358610
[TBL] [Abstract][Full Text] [Related]
15. Vanadium-induced chemokine mRNA expression and pulmonary inflammation.
Pierce LM; Alessandrini F; Godleski JJ; Paulauskis JD
Toxicol Appl Pharmacol; 1996 May; 138(1):1-11. PubMed ID: 8658498
[TBL] [Abstract][Full Text] [Related]
16. Intratracheally instilled mannosylated cationic liposome/NFκB decoy complexes for effective prevention of LPS-induced lung inflammation.
Wijagkanalan W; Kawakami S; Higuchi Y; Yamashita F; Hashida M
J Control Release; 2011 Jan; 149(1):42-50. PubMed ID: 20035809
[TBL] [Abstract][Full Text] [Related]
17. Efficient drug delivery to lung epithelial lining fluid by aerosolization of ciprofloxacin incorporated into PEGylated liposomes for treatment of respiratory infections.
Chono S; Suzuki H; Togami K; Morimoto K
Drug Dev Ind Pharm; 2011 Apr; 37(4):367-72. PubMed ID: 20815792
[TBL] [Abstract][Full Text] [Related]
18. Role of IL-18 in acute lung inflammation.
Jordan JA; Guo RF; Yun EC; Sarma V; Warner RL; Crouch LD; Senaldi G; Ulich TR; Ward PA
J Immunol; 2001 Dec; 167(12):7060-8. PubMed ID: 11739527
[TBL] [Abstract][Full Text] [Related]
19. DNA methyltransferase inhibitor alleviates bleomycin-induced pulmonary inflammation.
Lu CH; Chen CM; Ma J; Wu CJ; Chen LC; Kuo ML
Int Immunopharmacol; 2020 Jul; 84():106542. PubMed ID: 32361570
[TBL] [Abstract][Full Text] [Related]
20. In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation.
Ong HX; Benaouda F; Traini D; Cipolla D; Gonda I; Bebawy M; Forbes B; Young PM
Eur J Pharm Biopharm; 2014 Jan; 86(1):83-9. PubMed ID: 23851077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
